Paras Healthcare IPO 2026: Date, Price Band and Details

Dates, price band, lot size, financials and full details of the Paras Healthcare Limited IPO, sourced from the company's Red Herring Prospectus (RHP).
Paras Healthcare IPO at a glance
| Detail | Value |
| IPO Dates | 21 to 23 Oct 2026 |
| Price Band | ₹660 to ₹693 |
| Issue Size | ₹1,450 crore |
| Lot Size | 21 shares |
| Minimum Investment | ₹14,553 |
| Listing Date | 28 Oct 2026 |
Paras Healthcare Limited is bringing a Book Built Mainboard IPO worth about ₹1,450 crore. The issue is a mix of a fresh issue of ₹500 crore and an Offer for Sale (OFS) of ₹950 crore. The company receives money only from the fresh issue portion. The IPO is open from 21 October to 23 October 2026 and is proposed to list on the BSE and the NSE.
Paras Healthcare IPO Details
| Particulars | Details |
| IPO Type | Book Built Mainboard IPO (Fresh Issue + Offer for Sale) |
| Total Issue Size | ₹1,450 crore |
| Fresh Issue | ₹500 crore |
| Offer for Sale (OFS) | ₹950 crore (Dr. Dharminder Kumar Nagar ₹300 crore, Commelina Ltd ₹650 crore) |
| Price Band | ₹660 to ₹693 per share |
| Face Value | ₹1 per share |
| Lot Size | 21 shares |
| Minimum Retail Investment | ₹14,553 (1 lot, at upper price band) |
| Listing On | BSE and NSE |
| Lead Managers | JM Financial, BofA Securities India, Nuvama Wealth Management |
| Registrar | MUFG Intime India Private Limited |
Paras Healthcare IPO Timelines
| Event | Date |
| Anchor Investor Bidding | 19 October 2026 |
| IPO Opens | 21 October 2026 |
| IPO Closes | 23 October 2026 |
| Allotment | 26 October 2026 |
| Refund Initiation | 27 October 2026 |
| Credit of Shares to Demat | 27 October 2026 |
| Listing Date | 28 October 2026 |
Dates are tentative and may change.
Paras Healthcare IPO GMP
GMP stands for Grey Market Premium. It is the extra amount some traders are willing to pay for IPO shares in an informal market before listing, on top of the issue price. This market runs outside the stock exchanges, so the figure is unregulated, unverified, and can move sharply within a single day. A high GMP does not confirm a listing gain, and a low one does not rule it out, because it tracks short-term sentiment rather than the worth of the business. A steadier read on the IPO comes from the company's financials, how it uses the money, its valuation, and the risk factors set out in the Red Herring Prospectus (RHP).
About Paras Healthcare Limited
Paras Healthcare Limited was first incorporated in December 1987 as Arbian Frozen Foods Private Limited, moved into healthcare and took the Paras name in 2003, and converted into a public limited company in 2024. Based in Gurugram, Haryana, it is a clinical specialty-led hospital platform providing tertiary and quaternary (high-complexity) healthcare services.
It runs a network of eight hospitals with a total capacity of 2,211 beds as of 30 June 2026, under the "Paras Health" brand, across five states and one union territory: Gurugram and Panchkula (Haryana), Patna and Darbhanga (Bihar), Kanpur (Uttar Pradesh), Udaipur (Rajasthan), Ranchi (Jharkhand) and Srinagar (Jammu and Kashmir). Its clinical focus is on six specialty clusters it calls CONGOR: cardiac sciences, oncology sciences, neuro sciences, gastro sciences, orthopedics and sports injury, and renal sciences. These accounted for about 74.70% of revenue from operations in FY 2026. As of 30 June 2026 it had 1,084 doctors and 1,937 nurses, and it plans to grow to about 3,011 beds by March 2028 with new hospitals in Gurugram and Ludhiana.
The company's promoter is Dr. Dharminder Kumar Nagar.
What are the Key Strengths of Paras Healthcare (as stated in the RHP)
- One of the largest healthcare providers in North India, Bihar and Jharkhand, with a first-mover advantage and a well-recognised brand.
- Strong focus on tertiary and quaternary care with a high contribution from CONGOR specialties.
- Capital-efficient and flexible operating model with disciplined expansion.
- Delivering high-quality clinical care through renowned clinicians, supported with modern equipment.
- Digital technology enabling clinical effectiveness, patient experience and operational efficiencies.
- Doctor-led professional management team with proven execution capabilities.
What the Money Will Be Used For
This IPO has two parts. The Offer for Sale portion (₹950 crore) is the promoter, Dr. Dharminder Kumar Nagar (₹300 crore), and the investor shareholder Commelina Ltd (₹650 crore) selling part of their existing shares. The company receives nothing from this part.
From the fresh issue (₹500 crore), the company plans to use the net proceeds for:
| Purpose | Amount (from net proceeds) |
| Prepayment or repayment of certain company borrowings | ₹320.90 crore |
| Investment in wholly owned subsidiary PMHPL (which operates the Srinagar hospital) to repay or prepay its borrowings | ₹54.10 crore |
| General corporate purposes | Balance |
The amount for general corporate purposes will not exceed 25% of gross proceeds.
What are the Company Financials of Paras Healthcare
Restated consolidated figures, in ₹ crore.
| Particulars | FY 2026 | FY 2025 | FY 2024 | 2-Yr CAGR |
| Revenue from Operations | 1,605.95 | 1,294.06 | 1,129.04 | 19.26% |
| Total Income | 1,628.78 | 1,314.21 | 1,151.02 | 18.96% |
| EBITDA | 335.58 | 156.46 | 154.41 | 47.41% |
| Profit / (Loss) After Tax | 43.83 | (57.98) | (15.33) | N/A |
| Net Worth | 394.94 | 280.49 | 338.51 | 8.01% |
2-Yr CAGR is calculated from FY 2024 to FY 2026. Revenue grew steadily, and EBITDA roughly doubled (margin rose from 13.42% in FY 2024 to 20.60% in FY 2026). The company made losses at the PAT level in FY 2024 and FY 2025 and turned to a profit of ₹43.83 crore only in FY 2026, so a 2-year PAT growth rate cannot be calculated. Net Worth dipped in FY 2025 because of that year's loss, then recovered in FY 2026. EBITDA is the RHP's own measure (profit before tax plus finance costs plus depreciation).
Who Can Apply
Because the company did not meet the net-tangible-assets test under Regulation 6(1)(a), the offer is made under Regulation 6(2). The offer is split as follows:
| Category | Share of the Offer |
| Qualified Institutional Buyers (QIB) | Not less than 75% |
| Non-Institutional Investors (NII) | Not more than 15% |
| Retail Individual Investors (RII) | Not more than 10% |
How to Apply for the Paras Healthcare IPO
You can apply online through your broker app or through your bank's net banking using the Application Supported by Blocked Amount (ASBA) facility.
- Log in to your broker app or your bank's net banking.
- Open the IPO section and select Paras Healthcare IPO.
- Enter the number of lots and your bid price, or select the cut-off price.
- Enter your Unified Payments Interface (UPI) ID, or confirm your bank account for the ASBA route.
- Submit the application form.
- Approve the mandate request in your UPI app to block the funds until allotment.
How to Check Allotment Status
The basis of allotment is expected to be finalised on 26 October 2026. Once it is out, you can check your allotment status in three ways. You will need your PAN, application number, or DP/Client ID.
- On the registrar's website, MUFG Intime India, at the public issues page.
- On the BSE or NSE website under the IPO allotment section.
- Inside your broker app, under orders or IPO history.
Key Risk Factors
The RHP lists several risk factors. A few of the key ones are summarised below. Please read the full RHP for the complete list.
- The company made losses at the PAT level in FY 2024 and FY 2025 (and in the quarter ended June 2025), and turned to profit only in FY 2026.
- Two subsidiaries, Paras Healthcare (Ranchi) and Plus Medicare Hospitals, have had negative net worth or accumulated losses.
- It has substantial borrowings that need significant cash to service; its credit rating was placed on watch and downgraded in FY 2024.
- The business depends heavily on doctors, nurses and other healthcare staff, and on a few high-revenue CONGOR specialties and the in-patient department.
- Six of its eight hospitals operate on leased premises.
- The name of a member of its promoter group appears in the CIBIL wilful defaulter list.
- It does not own a registered trademark for the "Paras" brand name.
- The statutory auditors have included emphasis-of-matter paragraphs in their reports, and there have been delays in paying certain statutory dues.
- It operates in a highly regulated, price-controlled industry, and its empanelments with government health schemes have faced adverse actions in the past.
- The Offer for Sale portion delivers no money to the company; only the fresh issue does.
Frequently Asked Questions (FAQs)
1. When does the Paras Healthcare IPO open and close?
The IPO opens on 21 October 2026 and closes on 23 October 2026.
2. What is the price band of the IPO?
The price band is ₹660 to ₹693 per share.
3. What is the lot size?
One lot is 21 shares. Applications are made in multiples of 21 shares.
4. What is the minimum investment for retail investors?
The minimum investment is ₹14,553 at the upper price band (1 lot of 21 shares).
5. Is this IPO a fresh issue?
It is a mix. The IPO has a fresh issue of ₹500 crore and an Offer for Sale of ₹950 crore. The company receives money only from the fresh issue portion.
6. When is the allotment date?
The allotment is expected to be finalised on 26 October 2026, with shares credited to demat accounts by 27 October 2026.
7. When is the listing date?
The shares are proposed to be listed on the BSE and the NSE on 28 October 2026 (tentative).
8. What does Paras Healthcare do?
It runs a network of eight hospitals under the Paras Health brand across North India, Bihar and Jharkhand, focused on tertiary and quaternary care in specialties such as cardiac, oncology, neuro, gastro, orthopedics and renal sciences.
9. What is the GMP of the Paras Healthcare IPO?
GMP, or Grey Market Premium, is an informal pre-listing price that sits outside the stock exchanges and is neither regulated nor verified. It shifts with day-to-day sentiment and does not confirm how the shares will list. A more reliable picture comes from the company's financials, valuation, and the risks in the RHP.
Read the full Red Herring Prospectus (RHP): View the official RHP filed with SEBI and the exchanges.
Disclaimer: This page is for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any securities. All figures are sourced from the company's Red Herring Prospectus and public filings and may change. Investments in securities are subject to market risks. Please read all offer documents carefully and consult a registered financial advisor before making any investment decision.
